Kronos Worldwide (KRO) 10-Q 8 May 17 2017 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2017	May 01, 2017
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Trading Symbol	KRO
Entity Registrant Name	KRONOS WORLDWIDE INC
Entity Central Index Key	1,257,640
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		115,894,098

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 89.8	$ 50.7
Restricted cash	1.1	1.6
Accounts and other receivables	273.9	244.6
Inventories, net	360.7	343.5
Prepaid expenses and other	8.8	10
Total current assets	734.3	650.4
Other assets:
Investment in TiO2 manufacturing joint venture	82	78.9
Marketable securities	5.7	6
Deferred income taxes	5.7	8.1
Other	2	2.2
Total other assets	95.4	95.2
Property and equipment:
Land	37.9	37.3
Buildings	199.1	195.8
Equipment	975.5	947.4
Mining properties	109.8	108.1
Construction in progress	33.9	38.7
Gross property and equipment	1,356.2	1,327.3
Less accumulated depreciation and amortization	916.9	893.3
Net property and equipment	439.3	434
Total assets	1,269	1,179.6
Current liabilities:
Current maturities of long-term debt	3.6	3.6
Accounts payable and accrued liabilities	192.4	173.5
Income taxes	9.5	5
Total current liabilities	205.5	182.1
Noncurrent liabilities:
Long-term debt	360.9	335.4
Accrued pension cost	232	227.3
Accrued postretirement benefits cost	6.9	6.9
Deferred income taxes	11.6	10.5
Other	25.3	22.4
Total noncurrent liabilities	636.7	602.5
Stockholders' equity:
Common stock	1.2	1.2
Additional paid-in capital	1,398.8	1,398.8
Retained deficit	(532.8)	(552.2)
Accumulated other comprehensive loss	(440.4)	(452.8)
Total stockholders' equity	426.8	395
Total liabilities and stockholders' equity	1,269	1,179.6
Commitments and contingencies (Notes 11 and 13)

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income Statement [Abstract]
Net sales	$ 369.8	$ 318.4
Cost of sales	266.4	278
Gross margin	103.4	40.4
Selling, general and administrative expense	46.8	41.1
Other operating income (expense):
Currency transaction gains (losses), net	(0.2)	2.3
Other operating expense, net	(4.1)	(1.9)
Income (loss) from operations	52.3	(0.3)
Other income (expense):
Interest and dividend income	0.2	0.2
Interest expense	(4.7)	(5.1)
Income (loss) before income taxes	47.8	(5.2)
Income tax expense (benefit)	11	(1.4)
Net income (loss)	$ 36.8	$ (3.8)
Net income (loss) per basic and diluted share	$ 0.32	$ (0.03)
Cash dividends per share	$ 0.15	$ 0.15
Weighted average shares used in the calculation of net income (loss) per share	115.9	115.9

CONDENSED CONSOLIDATED STATEME4

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Net income (loss)	$ 36.8	$ (3.8)
Other comprehensive income (loss), net of tax:
Currency translation	9	14.4
Marketable securities	(0.2)	(0.2)
Interest rate swap	0.6	(2.8)
Total other comprehensive income, net	12.4	14.1
Comprehensive income	49.2	10.3
Defined Benefit Pension Plans
Other comprehensive income (loss), net of tax:
Defined benefit plans	3.1	2.8
OPEB
Other comprehensive income (loss), net of tax:
Defined benefit plans	$ (0.1)	$ (0.1)

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (unaudited) - USD ($) $ in Millions	Total	Common stock	Additional paid-in capital	Retained earnings (deficit)	Accumulated other comprehensive loss
Beginning Balance at Dec. 31, 2015					$ (412)
Net income	$ (3.8)
Other comprehensive income, net of tax	14.1
Ending Balance at Mar. 31, 2016					(397.9)
Beginning Balance at Dec. 31, 2016	395	$ 1.2	$ 1,398.8	$ (552.2)	(452.8)
Net income	36.8			36.8
Other comprehensive income, net of tax	12.4				12.4
Dividends paid	(17.4)			(17.4)
Ending Balance at Mar. 31, 2017	$ 426.8	$ 1.2	$ 1,398.8	$ (532.8)	$ (440.4)

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net income (loss)	$ 36.8	$ (3.8)
Depreciation and amortization	10.1	10.2
Deferred income taxes	3	(0.2)
Benefit plan expense greater than cash funding	3.7	2
Contributions to TiO2 manufacturing joint venture, net	(3.1)	(0.8)
Other, net	0.5	(1.6)
Change in assets and liabilities:
Accounts and other receivables	(26.8)	(16.5)
Inventories	(12.1)	19.5
Prepaid expenses	1.4	0.8
Accounts payable and accrued liabilities	21.5	(3.9)
Income taxes	4.7	(3.2)
Accounts with affiliates	(0.8)	(17.9)
Other, net	2.7	0.1
Net cash provided by (used in) operating activities	41.6	(15.3)
Cash flows from investing activities -
Capital expenditures	(11.9)	(14.3)
Net cash used in investing activities	(11.9)	(14.3)
Indebtedness:
Borrowings	42.2	9.2
Principal payments	(17.1)	(1)
Deferred financing fees	(0.1)
Dividends paid	(17.4)	(17.4)
Net cash provided by (used in) financing activities	7.6	(9.2)
Cash, cash equivalents and restricted cash - net change from:
Operating, investing and financing activities	37.3	(38.8)
Currency translation	1.3	1.3
Balance at beginning of period	52.3	94.3
Balance at end of period	90.9	56.8
Cash paid for:
Interest, net of amount capitalized	4.2	4.6
Income taxes	2.1	2.7
Accrual for capital expenditures	$ 4.2	$ 2.6

Organization and Basis of Prese

Organization and Basis of Presentation	3 Months Ended
	Mar. 31, 2017
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Organization and Basis of Presentation	Note 1 - Organization and basis of presentation: Organization At March 31, 2017, Valhi, Inc. (NYSE: VHI) held approximately 50% of our outstanding common stock and a wholly-owned subsidiary of NL Industries, Inc. (NYSE: NL) held approximately 30% of our common stock, Valhi owned approximately 83% of NL’s outstanding common stock and a wholly-owned subsidiary of Contran Corporation held approximately 93% of Valhi’s outstanding common stock. All of Contran’s outstanding voting stock is held by a family trust established for the benefit of Lisa K. Simmons and Serena Simmons Connelly and their children, for which Ms. Simmons and Ms. Connelly are co-trustees, or is held directly by Ms. Simmons and Ms. Connelly or entities related to them. Consequently, Ms. Simmons and Ms. Connelly may be deemed to control Contran, Valhi, NL and us. Basis of presentation - The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2016 that we filed with the Securities and Exchange Commission (SEC) on March 10, 2017 (2016 Annual Report). In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments) in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented. We have condensed the Consolidated Balance Sheet at December 31, 2016 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2016) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). Our results of operations for the interim period ended March 31, 2017 may not be indicative of our operating results for the full year. The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2016 Consolidated Financial Statements contained in our 2016 Annual Report. Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Kronos Worldwide, Inc. and its subsidiaries (NYSE: KRO) taken as a whole.

Accounts and Other Receivables

Accounts and Other Receivables	3 Months Ended
	Mar. 31, 2017
Receivables [Abstract]
Accounts and Other Receivables	Note 2 - Accounts and other receivables: December March 31, 2016 2017 (In millions) Trade receivables $ 224.8 $ 255.9 Recoverable VAT and other receivables 16.7 15.3 Receivable from affiliates: Income taxes, net - Valhi .7 - Other 2.8 3.3 Refundable income taxes .3 .1 Allowance for doubtful accounts (.7 ) (.7 ) Total $ 244.6 $ 273.9

Inventories, Net

Inventories, Net	3 Months Ended
	Mar. 31, 2017
Inventory Disclosure [Abstract]
Inventories, Net	Note 3 - Inventories, net: December March 31, 2016 2017 (In millions) Raw materials $ 68.7 $ 79.1 Work in process 22.3 22.1 Finished products 195.7 199.3 Supplies 56.8 60.2 Total $ 343.5 $ 360.7

Marketable Securities

Marketable Securities	3 Months Ended
	Mar. 31, 2017
Investments Debt And Equity Securities [Abstract]
Marketable Securities	Note 4 - Marketable securities: Our marketable securities consist of investments in the publicly-traded shares of related parties: Valhi, NL and CompX International Inc. NL owns the majority of CompX’s outstanding common stock. All of our marketable securities are accounted for as available-for-sale securities, which are carried at fair value using quoted market prices in active markets for each marketable security, and represent a Level 1 input within the fair value hierarchy. See Note 14. Because we have classified all of our marketable securities as available-for-sale, any unrealized gains or losses on the securities are recognized through other comprehensive income, net of deferred income taxes. Fair measurement Market Cost Marketable security level value basis Unrealized gain (In millions) December 31, 2016: Valhi common stock 1 $ 5.9 $ 3.2 $ 2.7 NL and CompX common stocks 1 .1 .1 - Total $ 6.0 $ 3.3 $ 2.7 March 31, 2017: Valhi common stock 1 $ 5.6 $ 3.2 $ 2.4 NL and CompX common stocks 1 .1 .1 - Total $ 5.7 $ 3.3 $ 2.4 At December 31, 2016 and March 31, 2017, we held approximately 1.7 million shares of Valhi’s common stock. We also held a nominal number of shares of CompX and NL common stocks. At December 31, 2016 and March 31, 2017, the quoted per share market price of Valhi’s common stock was $3.46 and $3.28, respectively. The Valhi, CompX and NL common stocks we own are subject to the restrictions on resale pursuant to certain provisions of SEC Rule 144. In addition, as a majority-owned subsidiary of Valhi we cannot vote our shares of Valhi common stock under Delaware General Corporation law, but we do receive dividends from Valhi on these shares, when declared and paid.

Other Noncurrent Assets

Other Noncurrent Assets	3 Months Ended
	Mar. 31, 2017
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
Other Noncurrent Assets	Note 5 - Other noncurrent assets: December March 31, 2016 2017 (In millions) Pension asset $ .6 $ .6 Deferred financing costs, net .4 .4 Other 1.2 1.0 Total $ 2.2 $ 2.0

Long-Term debt

Long-Term debt	3 Months Ended
	Mar. 31, 2017
Debt Disclosure [Abstract]
Long-Term Debt	Note 6 - Long-term debt: December 31, March 31, 2016 2017 (In millions) Term loan $ 335.9 $ 335.4 Revolving North American credit facility - 26.0 Other 3.1 3.1 Total debt 339.0 364.5 Less current maturities 3.6 3.6 Total long-term debt $ 335.4 $ 360.9 Term loan - During the first three months of 2017, we made our required quarterly term loan principal payment of $.9 million. The average interest rate on the term loan borrowings as of and for the quarter ended March 31, 2017 was 4.0%. The carrying value of the term loan at March 31, 2017 is stated net of unamortized original issue discount of $.8 million and debt issuance costs of $3.3 million. See Note 14 for a discussion of the interest rate swap we entered into in 2015 pursuant to our interest rate risk management strategy. North American revolving credit facility - In January 2017, we extended the maturity date of our North American revolving credit facility to the earlier of (i) January 30, 2022 or (ii) 90 days prior to the maturity date of our existing term loan indebtedness (or 90 days prior to the maturity date of any indebtedness incurred in a permitted refinancing of such existing term loan indebtedness). Based on the February 2020 maturity date of our existing term loan, the maturity date of the North American revolving credit facility is currently November 2019. During the first three months of 2017, we borrowed a net $26.0 million under our North American revolving credit facility. The average interest rate on outstanding borrowings as of and for the quarter ended March 31, 2017 was 4.75% and 4.72%, respectively. At March 31, 2017 we had approximately $74.9 million available for additional borrowing under this revolving credit facility. European revolving credit facility - Our European revolving credit facility requires the maintenance of certain financial ratios, and one of such requirements is based on the ratio of net debt to last twelve months earnings before income tax, interest, depreciation and amortization expense (EBITDA) of the borrowers. Based upon the borrowers’ last twelve months EBITDA as of March 31, 2017 and the net debt to EBITDA financial test, our borrowing availability at March 31, 2017 is approximately 69% of the credit facility, or €82.7 million ($88.3 million). We expect to extend the maturity date of this facility on or prior to its maturity date in September 2017. Other - We are in compliance with all of our debt covenants at March 31, 2017.

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	3 Months Ended
	Mar. 31, 2017
Payables And Accruals [Abstract]
Accounts Payable and Accrued Liabilities	Note 7 - Accounts payable and accrued liabilities: December March 31, 2016 2017 (In millions) Accounts payable $ 84.9 $ 101.5 Employee benefits 17.7 18.1 Accrued sales discounts and rebates 20.9 17.8 Reserve for uncertain tax positions 3.3 3.3 Interest rate swap contract 2.9 2.2 Accrued workforce reduction costs 1.2 .2 Payable to affiliates: Louisiana Pigment Company, L.P. 14.7 14.1 Income taxes, net - Valhi - .4 Other 27.9 34.8 Total $ 173.5 $ 192.4 See Note 14 for a discussion of the interest rate swap contract.

Other Noncurrent Liabilities

Other Noncurrent Liabilities	3 Months Ended
	Mar. 31, 2017
Other Liabilities Disclosure [Abstract]
Other Noncurrent Liabilities	Note 8 - Other noncurrent liabilities: December 31, March 31, 2016 2017 (In millions) Reserve for uncertain tax positions $ 7.3 $ 7.6 Employee benefits 7.8 7.9 Other 7.3 9.8 Total $ 22.4 $ 25.3

Employee Benefit Plans

Employee Benefit Plans	3 Months Ended
	Mar. 31, 2017
Compensation And Retirement Disclosure [Abstract]
Employee Benefit Plans	Note 9 - Employee benefit plans: Defined benefit plans - The components of net periodic defined benefit pension cost are presented in the table below. Three months ended March 31, 2016 2017 (In millions) Service cost $ 2.5 $ 2.7 Interest cost 3.8 3.3 Expected return on plan assets (3.8 ) (2.5 ) Amortization of prior service cost .2 .1 Recognized actuarial losses 2.8 3.2 Total $ 5.5 $ 6.8 Postretirement benefits - The components of net periodic postretirement benefits other than pension (OPEB) cost are presented in the table below. Three months ended March 31, 2016 2017 (In millions) Interest cost $ .1 $ .1 Amortization of prior service credit (.2 ) (.1 ) Total $ (.1 ) $ - Contributions -

Other Operating Income (Expense

Other Operating Income (Expense), Net	3 Months Ended
	Mar. 31, 2017
Other Operating Income Expense [Abstract]
Other Operating Income (Expense), Net	Note 10 - Other operating income (expense), net: Other operating income (expense), net in the first three months of 2016 includes income of $2.0 million related to cash received in the quarter from settlement of a business interruption insurance claim arising in 2014. We collected an additional $1.4 million related to this claim in April 2016, which was recognized as other operating income in the second quarter of 2016. No additional material amounts are expected to be received with respect to such insurance claim.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2017
Income Tax Disclosure [Abstract]
Income Taxes	Note 11 - Income taxes: Three months ended March 31, 2016 2017 (In millions) Expected tax expense (benefit), at U.S. federal statutory income tax rate of 35% $ (1.8 ) $ 16.7 Non-U.S. tax rates .2 (2.4 ) Incremental net tax expense (benefit) on earnings and losses of non-U.S. companies .2 1.2 Valuation allowance - (5.0 ) Other, net - .5 Income tax expense (benefit) $ (1.4 ) $ 11.0 Comprehensive provision for income taxes allocable to: Net income (loss) $ (1.4 ) $ 11.0 Other comprehensive income (loss): Marketable securities (.1 ) (.1 ) Pension plans .1 .2 Interest rate swap (1.6 ) .3 Total $ (3.0 ) $ 11.4 The amount shown in the above table of our income tax rate reconciliation for non-U.S. tax rates represents the result determined by multiplying the pre-tax earnings or losses of each of our non-U.S. subsidiaries by the difference between the applicable statutory income tax rate for each non-U.S. jurisdiction and the U.S. federal statutory tax rate of 35%. The amount shown on such table for incremental net tax expense (benefit) on earnings and losses on non-U.S. companies includes, as applicable, (i) current income taxes (including withholding taxes, if applicable), if any, associated with any current-year earnings of our non-U.S. subsidiaries to the extent such current-year earnings were distributed to us in the current year, (ii) deferred income taxes (or deferred income tax benefit) associated with the current-year change in the aggregate amount of undistributed earnings of our Canadian subsidiary, which earnings are not subject to a permanent reinvestment plan, in an amount representing the current-year change in the aggregate current income tax that would be generated (including withholding taxes, if applicable) when such aggregate undistributed earnings are distributed to us, and (iii) current U.S. income taxes (or current income tax benefit), including U.S. personal holding company tax, as applicable, attributable to current-year income (losses) of one of our non-U.S. subsidiaries, which subsidiary is treated as a dual resident for U.S. income tax purposes, to the extent the current-year income (losses) of such subsidiary is subject to U.S. income tax under the U.S. dual-resident provisions of the Internal Revenue Code. We have substantial net operating loss (NOL) carryforwards in Germany and Belgium, the benefit of which we had previously recognized under the more-likely-than-not recognition criteria. In the second quarter of 2015, we determined such losses did not meet the more-likely-than-not recognition criteria, and as a result we recognized a non-cash deferred income tax expense as a valuation allowance against our net deferred income tax assets in such jurisdictions. We continued to conclude such losses did not meet the more-likely-than-not recognition criteria through March 31, 2017. During the first quarter of 2017, we recognized an aggregate non-cash income tax benefit of $5.0 million as a result of a net decrease in such deferred income tax asset valuation allowance, due to utilizing a portion of both the German and Belgian NOLs during such period. Tax authorities are examining certain of our U.S. and non-U.S. tax returns and have or may propose tax deficiencies, including penalties and interest. Because of the inherent uncertainties involved in settlement initiatives and court and tax proceedings, we cannot guarantee that these matters will be resolved in our favor, and therefore our potential exposure, if any, is also uncertain. As a result of ongoing audits in certain jurisdictions, in 2008 we filed Advance Pricing Agreement Requests with the tax authorities in the U.S., Canada and Germany. These requests have been under review with the respective tax authorities since 2008 and prior to 2016, it was uncertain whether an agreement would be reached between the tax authorities and whether we would agree to execute and finalize such agreements. During 2016, Contran, as the ultimate parent of our U.S. Consolidated income tax group, executed and finalized an Advance Pricing Agreement with the U.S. Internal Revenue Service and our Canadian subsidiary executed and finalized an Advance Pricing Agreement with the Competent Authority for Canada (collectively, the “U.S.-Canada APA”) effective for tax years 2005 - 2015. Pursuant to the terms of the U.S.-Canada APA, the U.S. and Canadian tax authorities agreed to certain prior year changes to taxable income of our U.S. and Canadian subsidiaries. As a result of such agreed-upon changes, our Canadian subsidiary will incur a cash income tax payment of approximately CAD $3 million (USD $2.3 million) related to the U.S.-Canada APA, but such payment was fully offset by previously provided accruals (such USD $2.3 million has not been paid as of March 31, 2017, and is classified as part of income taxes payable at such date). We currently expect the Advance Pricing Agreement between Canada and Germany (collectively, the “Canada-Germany APA”) to be executed and finalized within the next twelve months. We believe we have adequate accruals to cover any cash income tax payment which might result from the finalization of the Canada-Germany APA, and accordingly we do not expect the execution of such APA to have a material adverse effect on our consolidated financial position, results of operations or liquidity. We believe we have adequate accruals for additional taxes and related interest expense which could ultimately result from tax examinations. We believe the ultimate disposition of tax examinations should not have a material adverse effect on our consolidated financial position, results of operations or liquidity. We currently estimate that our unrecognized tax benefits may decrease by approximately $6.4 million excluding accrued interest during the next twelve months related to certain adjustments to our prior year returns.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	3 Months Ended
	Mar. 31, 2017
Equity [Abstract]
Accumulated Other Comprehensive Loss	Note 12 - Accumulated other comprehensive loss: Changes in accumulated other comprehensive loss are presented in the table below. See Note 4 for further discussion of our marketable securities, Note 9 for discussion of our defined benefit pension plans and OPEB plans, and Note 14 for discussion of our interest rate swap contract. Three months ended March 31, 2016 2017 (In millions) Accumulated other comprehensive loss, net of tax: Currency translation: Balance at beginning of period $ (252.0 ) $ (269.6 ) Other comprehensive income 14.4 9.0 Balance at end of period $ (237.6 ) $ (260.6 ) Marketable securities: Balance at beginning of period $ (.6 ) $ 1.8 Other comprehensive loss - unrealized losses arising during the period (.2 ) (.2 ) Balance at end of period $ (.8 ) $ 1.6 Defined benefit pension plans: Balance at beginning of period $ (159.2 ) $ (184.8 ) Other comprehensive income - amortization of prior service cost and net losses included in net periodic pension cost 2.8 3.1 Balance at end of period $ (156.4 ) $ (181.7 ) OPEB plans: Balance at beginning of period $ 2.1 $ 1.8 Other comprehensive loss - amortization of prior service credit and net losses included in net periodic OPEB cost (.1 ) (.1 ) Balance at end of period $ 2.0 $ 1.7 Interest rate swap: Balance at beginning of period $ (2.3 ) $ (2.0 ) Other comprehensive income (loss): Unrealized losses arising during the period (3.4 ) - Less reclassification adjustment for amounts included in interest expense .6 .6 Balance at end of period $ (5.1 ) $ (1.4 ) Total accumulated other comprehensive loss: Balance at beginning of period $ (412.0 ) $ (452.8 ) Other comprehensive income 14.1 12.4 Balance at end of period $ (397.9 ) $ (440.4 )

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2017
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 13 - Commitments and contingencies: We are involved in various environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to our business. At least quarterly our management discusses and evaluates the status of any pending litigation to which we are a party. The factors considered in such evaluation include, among other things, the nature of such pending cases, the status of such pending cases, the advice of legal counsel and our experience in similar cases (if any). Based on such evaluation, we make a determination as to whether we believe (i) it is probable a loss has been incurred, and if so if the amount of such loss (or a range of loss) is reasonably estimable, or (ii) it is reasonably possible but not probable a loss has been incurred, and if so if the amount of such loss (or a range of loss) is reasonably estimable, or (iii) the probability a loss has been incurred is remote. In March 2013, we were served with the complaint, Los Gatos Mercantile, Inc. d/b/a Los Gatos Ace Hardware, et al v. E.I. Du Pont de Nemours and Company, et al. (United States District Court, for the Northern District of California, Case No. 3:13-cv-01180-SI). The defendants include us, E.I. Du Pont de Nemours & Company, Huntsman International LLC and Millennium Inorganic Chemicals, Inc. As amended by plaintiffs’ third amended complaint (Harrison, Jan, et al v. E.I. Du Pont de Nemours and Company, et al), plaintiffs seek to represent a class consisting of indirect purchasers of titanium dioxide in the states of Arizona, Arkansas, California, the District of Columbia, Florida, Iowa, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Hampshire, New Mexico, New York, North Carolina, Oregon and Tennessee that indirectly purchased titanium dioxide from one or more of the defendants on or after March 1, 2002. The complaint alleges that the defendants conspired and combined to fix, raise, maintain, and stabilize the price at which titanium dioxide was sold in the United States and engaged in other anticompetitive conduct. The case is now proceeding in the trial court. We believe the action is without merit, will deny all allegations of wrongdoing and liability and intend to defend against the action vigorously. Based on our quarterly status evaluation of this case, we have determined that it is not reasonably possible that a loss that is material has been incurred in this case. In September 2016, we were served with the complaint, Home Depot U.S.A., Inc. v. E.I. Dupont Nemours and Company, et al. (United States District Court, for the Northern District of California, Case No. 3:16-cv-04865). The defendants include us, E.I. Du Pont de Nemours & Company, Huntsman International LLC and Millennium Inorganic Chemicals, Inc. The plaintiff alleges that it indirectly purchased titanium dioxide from one or more of the defendants on or after March 1, 2002. The complaint alleges that the defendants conspired and combined to fix, raise, maintain, and stabilize the price at which titanium dioxide was sold in the United States and engaged in other anticompetitive conduct. The case is now proceeding in the trial court. We believe the action is without merit, will deny all allegations of wrongdoing and liability and intend to defend against the action vigorously. Based on our quarterly status evaluation of this case, we have determined that it is not reasonably possible that a loss has been incurred in this case.

Financial Instruments

Financial Instruments	3 Months Ended
	Mar. 31, 2017
Fair Value Disclosures [Abstract]
Financial Instruments	Note 14 - Financial instruments: The following table summarizes the valuation of our financial instruments recorded on a fair value basis as of December 31, 2016 and March 31, 2017: Fair Value Measurements Quoted Significant prices in other Significant active observable unobservable markets inputs inputs Total (Level 1) (Level 2) (Level 3) (In millions) Asset (liability) December 31, 2016: Interest rate swap contract $ (3.1 ) $ - $ (3.1 ) $ - Noncurrent marketable securities (See Note 4) 6.0 6.0 - - March 31, 2017: Interest rate swap contract $ (2.2 ) $ - $ (2.2 ) $ - Noncurrent marketable securities (See Note 4) 5.7 5.7 - - Our earnings and cash flows are subject to fluctuations due to changes in currency exchange rates and interest rates. Our risk management policy allows for the use of derivative financial instruments to prudently manage exposure to currency exchange rates and interest rates. Derivatives that we use are primarily currency forward contracts and interest rate swaps. We have not entered into these contracts for trading or speculative purposes in the past, nor do we currently anticipate entering into such contracts for trading or speculative purposes in the future. Currency forward contracts - Certain of our sales generated by our non-U.S. operations are denominated in U.S. dollars. We periodically use currency forward contracts to manage a very nominal portion of currency exchange rate risk associated with trade receivables denominated in a currency other than the holder’s functional currency or similar exchange rate risk associated with future sales. Derivatives used to hedge forecasted transactions and specific cash flows associated with financial assets and liabilities denominated in currencies other than the U.S. dollar and which meet the criteria for hedge accounting are designated as cash flow hedges. Consequently, the effective portion of gains and losses is deferred as a component of accumulated other comprehensive income and is recognized in earnings at the time the hedged item affects earnings. Contracts that do not meet the criteria for hedge accounting are marked-to-market at each balance sheet date with any resulting gain or loss recognized in income currently as part of net currency transaction gains and losses. The fair value of the currency forward contracts is determined using Level 1 inputs based on the currency spot forward rates quoted by banks or currency dealers. At December 31, 2016 and March 31, 2017, we had no currency forward contracts outstanding. We did not use hedge accounting for any of our contracts to the extent we held such contracts in 2016. Interest rate swap contract - As part of our interest rate risk management strategy, in August 2015 we entered into a pay- fixed/receive-variable interest rate swap contract with Wells Fargo Bank, N.A. to minimize our exposure to volatility in LIBOR as it relates to our forecasted outstanding variable-rate indebtedness. Under this interest rate swap, we will pay a fixed rate of 2.016% per annum, payable quarterly, and receive a variable rate of three-month LIBOR (subject to a 1.00% floor), also payable quarterly, in each case based on the notional amount of the swap then outstanding. The effective date of the swap contract was September 30, 2015. The notional amount of the swap started at $344.8 million and declines by $875,000 each quarter beginning December 31, 2015, with a final maturity of the swap contract in February 2020. The notional amount of the swap as of March 31, 2017 was $339.5 million. This swap contract has been designated as a cash flow hedge and qualified as an effective hedge at inception under ASC Topic 815. The effective portion of changes in fair value on this interest rate swap is recorded as a component of other comprehensive income, net of deferred income taxes. Commencing in the fourth quarter of 2015, as interest expense accrues on LIBOR-based variable rate debt, we classify the amount we pay under the pay-fixed leg of the swap and the amount we receive under the receive-variable leg of the swap as part of interest expense, with the net effect that the amount of interest expense we recognize on our LIBOR-based variable rate debt each quarter, as it relates to the notional amount of the swap outstanding each quarter, to be based on a fixed rate of 2.016% per annum in lieu of the level of LIBOR prevailing during the quarter. The amount of hedge ineffectiveness, if any, related to the swap will be recorded in earnings (also as part of interest expense). Since the inception of the swap through March 31, 2017, there have been no gains or losses recognized in earnings representing hedge ineffectiveness with respect to the interest rate swap. During the quarter ended March 31, 2017, the pretax amount recognized in other comprehensive income (loss) related to the interest rate swap contract was a $.9 million gain. During the same period, $.9 million was reclassified from accumulated other comprehensive loss into earnings (interest expense). During the next twelve months, the amount of the March 31, 2017 accumulated other comprehensive loss balance that is expected to be reclassified to interest expense is $3.0 million pre-tax. The fair value of the interest rate swap contract at March 31, 2017 was a current liability of $2.2 million and is reflected in the Condensed Consolidated Balance Sheet as part of accounts payable and accrued liabilities. See Note 7. The fair value of the interest rate swap was estimated by a third party using inputs that are observable or that can be corroborated by observable market data such as interest rate yield curves, and therefore, is classified within Level 2 of the valuation hierarchy. The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure as of December 31, 2016 and March 31, 2017. December 31, 2016 March 31, 2017 Carrying amount Fair value Carrying amount Fair value (In millions) Cash, cash equivalents and restricted cash $ 52.3 $ 52.3 $ 90.9 $ 90.9 Long-term debt: Variable rate: Term loan 335.9 334.6 335.4 340.8 Revolving North American credit facility - - 26.0 26.0 Common stockholders' equity 395.0 1,383.8 426.8 1,904.1 At March 31, 2017, the estimated market price of our term loan was $1,004 per $1,000 principal amount. The fair value of our term loan is based on quoted market prices; however, these quoted market prices represented Level 2 inputs because the markets in which the term loan trades were not active. The fair value of our common stockholders’ equity is based upon quoted market prices at each balance sheet date, which represent Level 1 inputs. Due to their near-term maturities, the carrying amounts of accounts receivable, accounts payable and the revolving credit facility are considered equivalent to fair value. See Notes 2, 6 and 7.

Recent Accounting Pronouncement

Recent Accounting Pronouncements Not Yet Adopted	3 Months Ended
	Mar. 31, 2017
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]
Recent Accounting Pronouncements not yet Adopted	Note 15 - Recent accounting pronouncements not yet adopted: In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606) In January 2016, the FASB issued ASU 2016-01, Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) In March 2017, the FASB issued ASU 2017-07, Compensation - Retirement Benefits (Topic 715) Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost We currently include all of our net benefit cost for defined benefit pension plans as part of compensation expense which is capitalized into inventory, we present a subtotal for income from operations and our net periodic defined benefit pension cost is currently included in the determination of income from operations. Accordingly, adoption of this standard will change the amount of our aggregate compensation cost capitalized in inventory, and change the determination of the amount we report as income from operations. As disclosed in Note 10 to our 2016 Annual Report, the service cost component represented approximately $9.9 million of our total net periodic defined benefit pension costs of $22.0 million in 2016. None of the components of our net OPEB cost, or our total OPEB cost, were material in 2016.

Organization and Basis of Pre22

Organization and Basis of Presentation (Policies)	3 Months Ended
	Mar. 31, 2017
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Organization	Organization At March 31, 2017, Valhi, Inc. (NYSE: VHI) held approximately 50% of our outstanding common stock and a wholly-owned subsidiary of NL Industries, Inc. (NYSE: NL) held approximately 30% of our common stock, Valhi owned approximately 83% of NL’s outstanding common stock and a wholly-owned subsidiary of Contran Corporation held approximately 93% of Valhi’s outstanding common stock. All of Contran’s outstanding voting stock is held by a family trust established for the benefit of Lisa K. Simmons and Serena Simmons Connelly and their children, for which Ms. Simmons and Ms. Connelly are co-trustees, or is held directly by Ms. Simmons and Ms. Connelly or entities related to them. Consequently, Ms. Simmons and Ms. Connelly may be deemed to control Contran, Valhi, NL and us.
Basis of Presentation	Basis of presentation - The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2016 that we filed with the Securities and Exchange Commission (SEC) on March 10, 2017 (2016 Annual Report). In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments) in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented. We have condensed the Consolidated Balance Sheet at December 31, 2016 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2016) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). Our results of operations for the interim period ended March 31, 2017 may not be indicative of our operating results for the full year. The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2016 Consolidated Financial Statements contained in our 2016 Annual Report. Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Kronos Worldwide, Inc. and its subsidiaries (NYSE: KRO) taken as a whole.
Derivatives	We periodically use currency forward contracts to manage a very nominal portion of currency exchange rate risk associated with trade receivables denominated in a currency other than the holder’s functional currency or similar exchange rate risk associated with future sales. Derivatives used to hedge forecasted transactions and specific cash flows associated with financial assets and liabilities denominated in currencies other than the U.S. dollar and which meet the criteria for hedge accounting are designated as cash flow hedges. Consequently, the effective portion of gains and losses is deferred as a component of accumulated other comprehensive income and is recognized in earnings at the time the hedged item affects earnings. Contracts that do not meet the criteria for hedge accounting are marked-to-market at each balance sheet date with any resulting gain or loss recognized in income currently as part of net currency transaction gains and losses.
New Accounting Pronouncements, Policy	In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606) In January 2016, the FASB issued ASU 2016-01, Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) In March 2017, the FASB issued ASU 2017-07, Compensation - Retirement Benefits (Topic 715) Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost We currently include all of our net benefit cost for defined benefit pension plans as part of compensation expense which is capitalized into inventory, we present a subtotal for income from operations and our net periodic defined benefit pension cost is currently included in the determination of income from operations. Accordingly, adoption of this standard will change the amount of our aggregate compensation cost capitalized in inventory, and change the determination of the amount we report as income from operations. As disclosed in Note 10 to our 2016 Annual Report, the service cost component represented approximately $9.9 million of our total net periodic defined benefit pension costs of $22.0 million in 2016. None of the components of our net OPEB cost, or our total OPEB cost, were material in 2016.

Accounts and Other Receivables

Accounts and Other Receivables (Tables)	3 Months Ended
	Mar. 31, 2017
Receivables [Abstract]
Accounts and Other Receivables	December March 31, 2016 2017 (In millions) Trade receivables $ 224.8 $ 255.9 Recoverable VAT and other receivables 16.7 15.3 Receivable from affiliates: Income taxes, net - Valhi .7 - Other 2.8 3.3 Refundable income taxes .3 .1 Allowance for doubtful accounts (.7 ) (.7 ) Total $ 244.6 $ 273.9

Inventories, Net (Tables)

Inventories, Net (Tables)	3 Months Ended
	Mar. 31, 2017
Inventory Disclosure [Abstract]
Schedule of Inventories, Net	December March 31, 2016 2017 (In millions) Raw materials $ 68.7 $ 79.1 Work in process 22.3 22.1 Finished products 195.7 199.3 Supplies 56.8 60.2 Total $ 343.5 $ 360.7

Marketable Securities (Tables)

Marketable Securities (Tables)	3 Months Ended
	Mar. 31, 2017
Investments Debt And Equity Securities [Abstract]
Marketable Securities	Fair measurement Market Cost Marketable security level value basis Unrealized gain (In millions) December 31, 2016: Valhi common stock 1 $ 5.9 $ 3.2 $ 2.7 NL and CompX common stocks 1 .1 .1 - Total $ 6.0 $ 3.3 $ 2.7 March 31, 2017: Valhi common stock 1 $ 5.6 $ 3.2 $ 2.4 NL and CompX common stocks 1 .1 .1 - Total $ 5.7 $ 3.3 $ 2.4

Other Noncurrent Assets (Tables

Other Noncurrent Assets (Tables)	3 Months Ended
	Mar. 31, 2017
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
Schedule of Other Noncurrent Assets	December March 31, 2016 2017 (In millions) Pension asset $ .6 $ .6 Deferred financing costs, net .4 .4 Other 1.2 1.0 Total $ 2.2 $ 2.0

Long-Term Debt (Tables)

Long-Term Debt (Tables)	3 Months Ended
	Mar. 31, 2017
Debt Disclosure [Abstract]
Components of Long Term Debt	December 31, March 31, 2016 2017 (In millions) Term loan $ 335.9 $ 335.4 Revolving North American credit facility - 26.0 Other 3.1 3.1 Total debt 339.0 364.5 Less current maturities 3.6 3.6 Total long-term debt $ 335.4 $ 360.9

Accounts Payable and Accrued 28

Accounts Payable and Accrued Liabilities (Tables)	3 Months Ended
	Mar. 31, 2017
Payables And Accruals [Abstract]
Components of Accounts Payable and Accrued Liabilities	December March 31, 2016 2017 (In millions) Accounts payable $ 84.9 $ 101.5 Employee benefits 17.7 18.1 Accrued sales discounts and rebates 20.9 17.8 Reserve for uncertain tax positions 3.3 3.3 Interest rate swap contract 2.9 2.2 Accrued workforce reduction costs 1.2 .2 Payable to affiliates: Louisiana Pigment Company, L.P. 14.7 14.1 Income taxes, net - Valhi - .4 Other 27.9 34.8 Total $ 173.5 $ 192.4

Other Noncurrent Liabilities (T

Other Noncurrent Liabilities (Tables)	3 Months Ended
	Mar. 31, 2017
Other Liabilities Disclosure [Abstract]
Components of Other Noncurrent Liabilities	December 31, March 31, 2016 2017 (In millions) Reserve for uncertain tax positions $ 7.3 $ 7.6 Employee benefits 7.8 7.9 Other 7.3 9.8 Total $ 22.4 $ 25.3

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	3 Months Ended
	Mar. 31, 2017
Defined Benefit Pension Plans
Components of Net Periodic Benefit Cost	Defined benefit plans - The components of net periodic defined benefit pension cost are presented in the table below. Three months ended March 31, 2016 2017 (In millions) Service cost $ 2.5 $ 2.7 Interest cost 3.8 3.3 Expected return on plan assets (3.8 ) (2.5 ) Amortization of prior service cost .2 .1 Recognized actuarial losses 2.8 3.2 Total $ 5.5 $ 6.8
OPEB
Components of Net Periodic Benefit Cost	Postretirement benefits - The components of net periodic postretirement benefits other than pension (OPEB) cost are presented in the table below. Three months ended March 31, 2016 2017 (In millions) Interest cost $ .1 $ .1 Amortization of prior service credit (.2 ) (.1 ) Total $ (.1 ) $ -

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2017
Income Tax Disclosure [Abstract]
Components of Effective Income Tax Rate Reconciliation and Comprehensive Provision for Income Taxes Allocation	Three months ended March 31, 2016 2017 (In millions) Expected tax expense (benefit), at U.S. federal statutory income tax rate of 35% $ (1.8 ) $ 16.7 Non-U.S. tax rates .2 (2.4 ) Incremental net tax expense (benefit) on earnings and losses of non-U.S. companies .2 1.2 Valuation allowance - (5.0 ) Other, net - .5 Income tax expense (benefit) $ (1.4 ) $ 11.0 Comprehensive provision for income taxes allocable to: Net income (loss) $ (1.4 ) $ 11.0 Other comprehensive income (loss): Marketable securities (.1 ) (.1 ) Pension plans .1 .2 Interest rate swap (1.6 ) .3 Total $ (3.0 ) $ 11.4

Accumulated Other Comprehensi32

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Mar. 31, 2017
Equity [Abstract]
Schedule of Changes in Accumulated Other Comprehensive Loss	Changes in accumulated other comprehensive loss are presented in the table below. See Note 4 for further discussion of our marketable securities, Note 9 for discussion of our defined benefit pension plans and OPEB plans, and Note 14 for discussion of our interest rate swap contract. Three months ended March 31, 2016 2017 (In millions) Accumulated other comprehensive loss, net of tax: Currency translation: Balance at beginning of period $ (252.0 ) $ (269.6 ) Other comprehensive income 14.4 9.0 Balance at end of period $ (237.6 ) $ (260.6 ) Marketable securities: Balance at beginning of period $ (.6 ) $ 1.8 Other comprehensive loss - unrealized losses arising during the period (.2 ) (.2 ) Balance at end of period $ (.8 ) $ 1.6 Defined benefit pension plans: Balance at beginning of period $ (159.2 ) $ (184.8 ) Other comprehensive income - amortization of prior service cost and net losses included in net periodic pension cost 2.8 3.1 Balance at end of period $ (156.4 ) $ (181.7 ) OPEB plans: Balance at beginning of period $ 2.1 $ 1.8 Other comprehensive loss - amortization of prior service credit and net losses included in net periodic OPEB cost (.1 ) (.1 ) Balance at end of period $ 2.0 $ 1.7 Interest rate swap: Balance at beginning of period $ (2.3 ) $ (2.0 ) Other comprehensive income (loss): Unrealized losses arising during the period (3.4 ) - Less reclassification adjustment for amounts included in interest expense .6 .6 Balance at end of period $ (5.1 ) $ (1.4 ) Total accumulated other comprehensive loss: Balance at beginning of period $ (412.0 ) $ (452.8 ) Other comprehensive income 14.1 12.4 Balance at end of period $ (397.9 ) $ (440.4 )

Financial Instruments (Tables)

Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2017
Fair Value Disclosures [Abstract]
Valuation of Financial Instruments Recorded on Fair Value Basis	The following table summarizes the valuation of our financial instruments recorded on a fair value basis as of December 31, 2016 and March 31, 2017: Fair Value Measurements Quoted Significant prices in other Significant active observable unobservable markets inputs inputs Total (Level 1) (Level 2) (Level 3) (In millions) Asset (liability) December 31, 2016: Interest rate swap contract $ (3.1 ) $ - $ (3.1 ) $ - Noncurrent marketable securities (See Note 4) 6.0 6.0 - - March 31, 2017: Interest rate swap contract $ (2.2 ) $ - $ (2.2 ) $ - Noncurrent marketable securities (See Note 4) 5.7 5.7 - -
Financial Instruments not Carried at Fair Value but which Require Fair Value Disclosure	The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure as of December 31, 2016 and March 31, 2017. December 31, 2016 March 31, 2017 Carrying amount Fair value Carrying amount Fair value (In millions) Cash, cash equivalents and restricted cash $ 52.3 $ 52.3 $ 90.9 $ 90.9 Long-term debt: Variable rate: Term loan 335.9 334.6 335.4 340.8 Revolving North American credit facility - - 26.0 26.0 Common stockholders' equity 395.0 1,383.8 426.8 1,904.1

Organization and Basis of Pre34

Organization and Basis of Presentation - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2017
Valhi Inc
Organization And Basis Of Presentation [Line Items]
Ownership percentage in subsidiary	50.00%
Ownership percentage in company	83.00%
NL Industries Inc.
Organization And Basis Of Presentation [Line Items]
Ownership percentage	30.00%
Contran
Organization And Basis Of Presentation [Line Items]
Ownership percentage of parent company held by related party	93.00%
Controlling interest description	Consequently, Ms. Simmons and Ms. Connelly may be deemed to control Contran, Valhi, NL and us.

Accounts and Other Receivable35

Accounts and Other Receivables - Accounts and Other Receivables (Detail) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Accounts Notes And Loans Receivable [Line Items]
Allowance for doubtful accounts	$ (0.7)	$ (0.7)
Total	273.9	244.6
Trade receivables
Accounts Notes And Loans Receivable [Line Items]
Accounts and other receivables	255.9	224.8
Recoverable VAT and other receivables
Accounts Notes And Loans Receivable [Line Items]
Accounts and other receivables	15.3	16.7
Other
Accounts Notes And Loans Receivable [Line Items]
Receivable from affiliates	3.3	2.8
Refundable income taxes
Accounts Notes And Loans Receivable [Line Items]
Refundable income taxes	$ 0.1	0.3
Valhi | Income taxes, net
Accounts Notes And Loans Receivable [Line Items]
Receivable from affiliates		$ 0.7

Inventories, Net - Schedule of

Inventories, Net - Schedule of Inventories, Net (Detail) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Inventory Disclosure [Abstract]
Raw materials	$ 79.1	$ 68.7
Work in process	22.1	22.3
Finished products	199.3	195.7
Supplies	60.2	56.8
Total	$ 360.7	$ 343.5

Marketable Securities - Classif

Marketable Securities - Classification of Marketable Securities (Detail) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Schedule Of Available For Sale Securities [Line Items]
Market value	$ 5.7	$ 6
Cost basis	3.3	3.3
Unrealized gain	2.4	2.7
Level 1 | Common stock | Valhi
Schedule Of Available For Sale Securities [Line Items]
Market value	5.6	5.9
Cost basis	3.2	3.2
Unrealized gain	2.4	2.7
Level 1 | Common stock | NL And CompX
Schedule Of Available For Sale Securities [Line Items]
Market value	0.1	0.1
Cost basis	$ 0.1	$ 0.1

Marketable Securities - Additio

Marketable Securities - Additional Information (Detail) - Valhi Inc - Common stock - $ / shares shares in Millions	Mar. 31, 2017	Dec. 31, 2016
Schedule Of Available For Sale Securities [Line Items]
Investments in publicly-traded shares	1.7	1.7
Quoted market price of per share	$ 3.28	$ 3.46

Other Noncurrent Assets - Sched

Other Noncurrent Assets - Schedule of Other Noncurrent Assets (Detail) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Disclosure Other Non Current Assets Schedule Of Other Non Current Assets [Abstract]
Pension asset	$ 0.6	$ 0.6
Deferred financing costs, net	0.4	0.4
Other	1	1.2
Total	$ 2	$ 2.2

Long-Term Debt - Components of

Long-Term Debt - Components of Long-Term Debt (Detail) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Debt Disclosure [Abstract]
Term loan	$ 335.4	$ 335.9
Revolving North American credit facility	26
Other	3.1	3.1
Total debt	364.5	339
Less current maturities	3.6	3.6
Total long-term debt	$ 360.9	$ 335.4

Long-Term Debt - Term Loan - Ad

Long-Term Debt - Term Loan - Additional Information (Detail) - Term Loan $ in Millions	3 Months Ended
	Mar. 31, 2017USD ($)
Debt Instrument [Line Items]
Quarterly principal payment	$ 0.9
Percentage of average interest rate, at period end	4.00%
Percentage of average interest rate, during period	4.00%
Unamortized discount	$ 0.8
Debt Issuance Cost	$ 3.3

Long-Term Debt - Revolving Cred

Long-Term Debt - Revolving Credit Facilities - Additional Information (Detail) € in Millions, $ in Millions	1 Months Ended		3 Months Ended
	Jan. 31, 2017	Feb. 28, 2014	Mar. 31, 2017USD ($)	Mar. 31, 2017EUR (€)
European Revolving Credit Facility
Line Of Credit Facility [Line Items]
Line of Credit Maturity			2017-09
Amount available for Borrowing			$ 88.3	€ 82.7
Percentage of borrowings available under credit facility			69.00%	69.00%
Term Loan
Line Of Credit Facility [Line Items]
Debt instrument maturity date		Feb. 29, 2020
North American Revolving Credit Facility
Line Of Credit Facility [Line Items]
Net amount of borrowings under credit facility during the period			$ 26
Average interest rate at period end			4.75%	4.75%
Average interest rate during period			4.72%
Amount available for additional borrowing			$ 74.9
Line of credit maturity, description	In January 2017, we extended the maturity date of our North American revolving credit facility to the earlier of (i) January 30, 2022 or (ii) 90 days prior to the maturity date of our existing term loan indebtedness (or 90 days prior to the maturity date of any indebtedness incurred in a permitted refinancing of such existing term loan indebtedness). Based on the February 2020 maturity date of our existing term loan, the maturity date of the North American revolving credit facility is currently November 2019.
North American Revolving Credit Facility | Maturity Date Option 1
Line Of Credit Facility [Line Items]
Line of credit, maturity date	Jan. 30, 2022
North American Revolving Credit Facility | Maturity Date Option 2
Line Of Credit Facility [Line Items]
Maturity date of term loan	90 days
Line of Credit Maturity	2019-11

Accounts Payable and Accrued 43

Accounts Payable and Accrued Liabilities - Components of Accounts Payable and Accrued Liabilities (Detail) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Accounts Payable And Accrued Liabilities [Line Items]
Accounts payable	$ 101.5	$ 84.9
Employee benefits	18.1	17.7
Accrued sales discounts and rebates	17.8	20.9
Reserve for uncertain tax positions	3.3	3.3
Interest rate swap contract	2.2	2.9
Accrued workforce reduction costs	0.2	1.2
Other	34.8	27.9
Total	192.4	173.5
Louisiana Pigment Company, L.P.
Accounts Payable And Accrued Liabilities [Line Items]
Payable to affiliates	14.1	$ 14.7
Valhi | Income taxes, net
Accounts Payable And Accrued Liabilities [Line Items]
Payable to affiliates	$ 0.4

Other Noncurrent Liabilities -

Other Noncurrent Liabilities - Components of Other Noncurrent Liabilities (Detail) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Other Liabilities Noncurrent [Abstract]
Reserve for uncertain tax positions	$ 7.6	$ 7.3
Employee benefits	7.9	7.8
Other	9.8	7.3
Total	$ 25.3	$ 22.4

Employee Benefit Plans - Compon

Employee Benefit Plans - Components of Net Periodic Benefit Cost (Detail) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Defined Benefit Plan Disclosure [Line Items]
Service cost			$ 9.9
Total			$ 22
Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 2.7	$ 2.5
Interest cost	3.3	3.8
Expected return on plan assets	(2.5)	(3.8)
Amortization of prior service cost	0.1	0.2
Recognized actuarial losses	3.2	2.8
Total	6.8	5.5
OPEB
Defined Benefit Plan Disclosure [Line Items]
Interest cost	0.1	0.1
Amortization of prior service cost	$ (0.1)	(0.2)
Total		$ (0.1)

Employee Benefit Plans - Additi

Employee Benefit Plans - Additional Information (Detail) $ in Millions	3 Months Ended
	Mar. 31, 2017USD ($)
Compensation And Retirement Disclosure [Abstract]
Expected contributions for pension plans in 2017	$ 15

Other Operating Income (Expen47

Other Operating Income (Expense), Net - Additional Information (Detail) - USD ($)	3 Months Ended
	Jun. 30, 2016	Mar. 31, 2016	Mar. 31, 2017
Other Operating Income And Expense [Line Items]
Insurance settlements receivable			$ 0
Other Operating Income (Expense), Net
Other Operating Income And Expense [Line Items]
Income received from settlement of business interruption insurance claim	$ 1,400,000	$ 2,000,000

Income Taxes - Components of Ef

Income Taxes - Components of Effective Income Tax Rate Reconciliation and Comprehensive Provision for Income Taxes Allocation (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Schedule Of Income Tax [Line Items]
Expected tax expense (benefit), at U.S. federal statutory income tax rate of 35%	$ 16.7	$ (1.8)
Non-U.S. tax rates	(2.4)	0.2
Incremental net tax expense (benefit) on earnings and losses of non-U.S. companies	1.2	0.2
Valuation allowance	(5)
Other, net	0.5
Income tax expense (benefit)	11	(1.4)
Comprehensive provision for income taxes allocable to:
Net income (loss)	11	(1.4)
Other comprehensive income (loss):
Marketable securities	(0.1)	(0.1)
Interest rate swap	0.3	(1.6)
Total	11.4	(3)
Defined Benefit Pension Plans
Other comprehensive income (loss):
Benefit plans	$ 0.2	$ 0.1

Income Taxes - Components of 49

Income Taxes - Components of Effective Income Tax Rate Reconciliation and Comprehensive Provision for Income Taxes Allocation (Parenthetical) (Detail)	3 Months Ended
	Mar. 31, 2017
Income Tax Disclosure [Abstract]
U.S. Federal statutory income tax rate	35.00%

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) CAD in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2017USD ($)	Mar. 31, 2017CAD	Dec. 31, 2016USD ($)
Income Tax [Line Items]
U.S. Federal statutory income tax rate	35.00%
Income taxes	$ 9.5		$ 5
Decrease in unrecognized tax benefits excluding interest related to certain adjustments	$ 6.4
US-Canada APA
Income Tax [Line Items]
U.S.-Canada Advance Pricing Agreement, description	Tax authorities are examining certain of our U.S. and non-U.S. tax returns and have or may propose tax deficiencies, including penalties and interest. Because of the inherent uncertainties involved in settlement initiatives and court and tax proceedings, we cannot guarantee that these matters will be resolved in our favor, and therefore our potential exposure, if any, is also uncertain. As a result of ongoing audits in certain jurisdictions, in 2008 we filed Advance Pricing Agreement Requests with the tax authorities in the U.S., Canada and Germany. These requests have been under review with the respective tax authorities since 2008 and prior to 2016, it was uncertain whether an agreement would be reached between the tax authorities and whether we would agree to execute and finalize such agreements. During 2016, Contran, as the ultimate parent of our U.S. Consolidated income tax group, executed and finalized an Advance Pricing Agreement with the U.S. Internal Revenue Service and our Canadian subsidiary executed and finalized an Advance Pricing Agreement with the Competent Authority for Canada (collectively, the “U.S.-Canada APA”) effective for tax years 2005 - 2015.
US-Canada APA | Canadian Subsidiary
Income Tax [Line Items]
Income tax payable	$ 2.3	CAD 3
Income taxes	$ 2.3
US-Canada APA | Canada Revenue Agency | Canadian Subsidiary | Earliest Tax Year
Income Tax [Line Items]
Effective tax year	2,005
US-Canada APA | Canada Revenue Agency | Canadian Subsidiary | Latest Tax Year
Income Tax [Line Items]
Effective tax year	2,015
Germany and Belgium
Income Tax [Line Items]
Increase (decrease) in non-cash deferred income tax asset valuation allowance	$ (5)

Accumulated Other Comprehensi51

Accumulated Other Comprehensive Loss - Schedule of Changes in Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance	$ 395
Ending Balance	426.8
Currency Translation
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance	(269.6)	$ (252)
Other comprehensive income (loss)	9	14.4
Ending Balance	(260.6)	(237.6)
Marketable Securities
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance	1.8	(0.6)
Other comprehensive income (loss)	(0.2)	(0.2)
Ending Balance	1.6	(0.8)
Accumulated Defined Benefit Plans Adjustment | Defined Benefit Pension Plans
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance	(184.8)	(159.2)
Other comprehensive income (loss)	3.1	2.8
Ending Balance	(181.7)	(156.4)
Accumulated Defined Benefit Plans Adjustment | OPEB Plans
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance	1.8	2.1
Other comprehensive income (loss)	(0.1)	(0.1)
Ending Balance	1.7	2
Interest Rate Swap
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance	(2)	(2.3)
Other comprehensive income (loss)		(3.4)
Less reclassification adjustment	0.6	0.6
Ending Balance	(1.4)	(5.1)
Total Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance	(452.8)	(412)
Other comprehensive income (loss)	12.4	14.1
Ending Balance	$ (440.4)	$ (397.9)

Commitments and contingencies -

Commitments and contingencies - Additional Information (Detail)	Mar. 31, 2017Litigation
Commitments And Contingencies Disclosure [Abstract]
Number of pending matters	2

Financial Instruments - Valuati

Financial Instruments - Valuation of Financial Instruments Recorded on Fair Value Basis (Detail) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Noncurrent marketable securities	$ 5.7	$ 6
Fair Value Measurements Recurring
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate swap contract	(2.2)	(3.1)
Noncurrent marketable securities	5.7	6
Fair Value Measurements Recurring | Level 1
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Noncurrent marketable securities	5.7	6
Fair Value Measurements Recurring | Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate swap contract	$ (2.2)	$ (3.1)

Financial Instruments - Additio

Financial Instruments - Additional Information (Detail)	3 Months Ended	12 Months Ended
	Mar. 31, 2017USD ($)DerivativeContract	Dec. 31, 2016USD ($)DerivativeContract	Dec. 31, 2015USD ($)
Financial Instrument At Fair Value [Line Items]
Fair value of interest rate swap contract, current	$ 2,200,000	$ 2,900,000
Term Loan
Financial Instrument At Fair Value [Line Items]
Debt instrument base principal amount	1,000
Debt instrument estimated market price per $1000 principal amount	$ 1,004
Currency Forward Contracts
Financial Instrument At Fair Value [Line Items]
Number of derivative contacts outstanding | DerivativeContract	0	0
Interest Rate Swap
Financial Instrument At Fair Value [Line Items]
Gain loss recognized in earnings on hedge ineffectiveness	$ 0
Pretax gain amount recognized in other comprehensive income (loss) related to interest rate swap contract	900,000
Reclassified from accumulated other comprehensive loss in to earnings (interest expense)	900,000
Pre-tax amount of accumulated other comprehensive loss expected to be reclassified to interest expense during next twelve months	3,000,000
Interest Rate Swap | Accounts Payable and Accrued Liabilities
Financial Instrument At Fair Value [Line Items]
Fair value of interest rate swap contract, current	$ 2,200,000
Interest Rate Swap | London Interbank Offered Rate (LIBOR)
Financial Instrument At Fair Value [Line Items]
Derivative, type of instrument	pay-fixed/receive-variable interest rate swap
Interest rate swap, type of interest rate	fixed
Interest rate swap, fixed rate	2.016%
Interest rate swap, floor rate	1.00%
Interest rate swap, effective date	Sep. 30, 2015
Derivative instrument, notional amount	$ 339,500,000		$ 344,800,000
Interest rate swap, notional amount decline each quarter	$ 875,000
Interest rate swap, notional amount decline commencing date	Dec. 31, 2015
Interest rate swap, final maturity date	Feb. 29, 2020

Financial Instruments - Financi

Financial Instruments - Financial Instruments not Carried at Fair Value but which Require Fair Value Disclosure (Detail) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Fair Value Disclosures [Abstract]
Cash, cash equivalents and restricted cash, Carrying amount	$ 90.9	$ 52.3	$ 56.8	$ 94.3
Variable rate, Term loan, Carrying amount	335.4	335.9
Variable rate, Revolving North American credit facility, Carrying amount	26
Common stockholders' equity, Carrying amount	426.8	395
Cash, cash equivalents and restricted cash, Fair value	90.9	52.3
Variable rate, Term loan, Fair value	340.8	334.6
Variable rate, Revolving North American credit facility, Fair value	26
Common stockholders' equity, Fair value	$ 1,904.1	$ 1,383.8

Recent Accounting Pronounceme56

Recent Accounting Pronouncements Not Yet Adopted - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]
Service cost	$ 9.9
Net periodic defined benefit pension costs	$ 22